American Heart Journal
Volume 138, Issue 3 , Pages 403-413 , September 1999

Clinical features of Wolff-Parkinson-White syndrome

Received 15 June 1998 ,Accepted 30 December 1998.

References 

  1. Durrer D, Schuilenburg RM, Wellens HJJ. Pre-excitation revisited. Am J Cardiol. 1970;25:690–697
  2. Kent AFS. The structure of cardiac tissues at the auricular ventricular junction: proceedings of the Physiological Society. J Physiol (Lond). 1913;47:17–19
  3. Wolff L, Parkinson J, White PD. Bundle-branch block with short PR interval in healthy young people prone to paroxysmal tachycardia. Am Heart J. 1930;5:685–704
  4. Holzman M, Scherf D. Uber Elektrokardiogramme met verkurzter vorhof-kammer distanz und positiven P zachen. Ztschr Klin Med. 1932;121:404–423
  5. Wolferth CC, Wood FC. The mechanism of production of short PR intervals and prolonged QRS complexes in patients with presumably undamaged hearts: hypothesis of an accessory pathway of auriculoventricular conduction (bundle of Kent). Am Heart J. 1933;8:297–311
  6. Ohnell RF. Pre-excitation, a cardiac abnormality. Acta Med Scand. 1944;152:1–167
  7. Wood FC, Wolferth CC, Geckeler GD. Histologic demonstration of accessory muscular connections between auricle and ventricle in a case of short PR interval and prolonged QRS complex. Am Heart J. 1943;25:454–462
  8. Becker AE, Anderson RH, Durrer D, et al.  The anatomical substrates of Wolff-Parkinson-White syndrome: a clinicopatholologic correlation in 7 patients. Circulation. 1978;57:870–879
  9. Peters NS, Rowland E, Bennett JG, et al.  The Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway. Eur Heart J. 1994;15:981–987
  10. Dunnigan A. Developmental aspects and natural history of preexcitation syndromes. In: 1st edition.  Benditt DG,  Benson BW editor. Cardiac pre-excitation syndromes: Origins, evaluation, and treatment. Boston: Martinus Nijhoff Publishing; 1986;p. 21–29
  11. Lunel AAV. Significance of annulus fibrosis of heart in relation to AV conduction and ventricular activation in cases of Wolff-Parkinson-White syndrome. Br Heart J. 1972;34:1263–1271
  12. Anderson RH, Becker AE, Brechenmacher C, et al.  Ventricular pre-excitation: a proposed nomenclature for its substrates. Eur J Cardiol. 1975;3:27–36
  13. Sung RJ, Tai DY. Electrophysiologic characteristics of accessory connections: an overview. In: 1st edition.  Benditt DG,  Benson DW editor. Cardiac pre-excitation syndromes: Origins, evaluation, and treatment. Boston: Martinus Nijhoff Publishing; 1986;p. 165–199
  14. Zipes DP, DeJoseph RL, Rothbaum DA. Unusual properties of accessory pathways. Circulation. 1974;49:1200–1211
  15. Wellens HJJ, Durrer D. Patterns of ventriculo-atrial conduction in the Wolff-Parkinson-White syndrome. Circulation. 1974;49:22–31
  16. Wellens HJJ, Durrer D. The role of an accessory atrioventricular pathway in reciprocal tachycardia: observations in patients with and without the Wolff-Parkinson-White syndrome. Circulation. 1975;52:58–72
  17. Wellens HJJ. The electrophysiologic properties of the accessory pathway in the Wolff-Parkinson-White syndrome. In:  Wellens HJJ,  Lie KI,  Janse MJ editor. The conduction system of the heart: structure, function, and clinical implications. Philadelphia: Lea & Febiger; 1976;p. 567–587
  18. Guize L, Soria R, Chaouat JC, et al.  Prévalence et évolution du syndrome de Wolff-Parkinson-White dans une population de 138 048 sujets. Ann Med Interne. 1985;136:474–478
  19. Averill KH, Fosmoe RJ, Lamb LE. Electrocardiographic findings in 67,375 asymptomatic subjects, IV: Wolff-Parkinson-White syndrome. Am J Cardiol. 1960;6:108–129
  20. Hejtmancik MR, Herrmann GR. The electrocardiographic syndrome of short PR interval and broad QRS complexes: a clinical study of 80 cases. Am Heart J. 1957;54:708–721
  21. Manning GW. Electrocardiography in the selection of royal Canadian air force aircrew. Circulation. 1954;10:401–412
  22. Sano S, Komori S, Amano T, et al.  Prevalence of ventricular preexcitation in Japanese schoolchildren. Heart. 1998;79:374–378
  23. Munger TM, Packer DL, Hammill SC, et al.  A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted county, Minnesota, 1953-1989. Circulation. 1993;87:866–873
  24. Schneider RG. Familial occurrence of Wolff-Parkinson-White syndrome. Am Heart J. 1969;78:34–36
  25. Chia BL, Yew FC, Chay SO, et al.  Familial Wolff-Parkinson-White syndrome. J Electrocardiol. 1982;15:195–198
  26. Harnischfeger WW. Hereditary occurrence of the pre-excitation (Wolff-Parkinson-White) syndrome with re-entry mechanism and concealed conduction. Circulation. 1959;19:28–40
  27. Gillette PC, DeBow F, McNamara DG. A proposed autosomal dominant method of inheritance of the Wolff-Parkinson-White syndrome and supraventricular tachycardia. J Pediatr. 1978;93:257–258
  28. Vidaillet JR, Pressley JC, Henke E, et al.  Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med. 1987;317:65–69
  29. Gallagher JJ, Gilbert M, Svenson RH, et al.  Wolff-Parkinson-White syndrome: the problem, evaluation, and surgical correction. Circulation. 1975;51:767–785
  30. Greene HL. Accessory atrioventricular conduction syndromes: a review. Johns Hopkins Med J. 1976;139:3–19
  31. Gallagher JJ, Pritchett ELC, Sealy WC, et al.  The preexcitation syndromes. Prog Cardiovasc Dis. 1978;20:285–327
  32. Swiderski J, Lees MH, Nadas AS. The Wolff-Parkinson-White syndrome in infancy and childhood. Br Heart J. 1962;24:561–579
  33. Fananapazir L, Tracy CM, Leon MB, et al.  Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: a consecutive analysis in 155 patients. Circulation. 1989;80:1259–1268
  34. Chen WWC, Wong PHC, Chow JSF. Mitral valve prolapse and pre-excitation. PACE. 1982;5:773–775
  35. Baldwin RN, Lane RJ. Development of Wolff-Parkinson-White syndrome in a patient with Friedreich’s ataxia. J Neurol Neurosurg Psychiatry. 1987;50:235–236
  36. Jayakar PB, Stanwick RS, Seshia SS. Tuberous sclerosis and Wolff-Parkinson-White syndrome. J Pediatr. 1985;108:259–260
  37. Cappato R, Alboni P, Paparella N, et al.  Destrocardia e sindrome di Wolff-Parkinson-White. Diagnosi electrocardiografica. G Ital Cardiol. 1986;16:92–94
  38. Nikoskelainen EK, Savontaus M, Huoponen K, et al.  Pre-excitation syndrome in Leber’s hereditary optic neuropathy. Lancet. 1994;344:857–858
  39. Banerjee AK. Marfan’s syndrome associated with Wolff-Parkinson-White syndrome type B. Jpn Heart J. 1988;29:377–380
  40. Shah K, Walsh K. Giant right atrial diverticulum: an unusual cause of Wolff-Parkinson-White syndrome. Br Heart J. 1992;68:58–59
  41. Guiraudon GM, Guiraudon CM, Klein GJ, et al.  The coronary sinus diverticulum: a pathologic entity associated with the Wolff-Parkinson-White syndrome. Am J Cardiol. 1988;62:733–735
  42. Segers PM, Lequime J, Denolin H. L’activation ventriculaire précoce de certains c rs hyperexcitables: Étude de l’onde de l’ électrocardiogramme. Cardiologia. 1944;8:113–167
  43. Cohen TJ, Tucker KJ, Abbott JA, et al.  Usefulness of adenosine in augmenting ventricular preexcitation for noninvasive localization of accessory pathways. Am J Cardiol. 1992;69:1178–1185
  44. Reddy GV, Schamroth L. The localization of bypass tracts in the Wolff-Parkinson-White syndrome from the surface electrocardiogram. Am Heart J. 1987;113:984–993
  45. Lesh MD, Hare GFV, Schamp DJ, et al.  Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. J Am Coll Cardiol. 1992;19:1303–1309
  46. Arruda MS, McClelland JH, Wang X, et al.  Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol. 1998;9:2–12
  47. Wang K, Asinger R, Hodges M. Electrocardiograms of Wolff-Parkinson-White syndrome simulating other conditions. Am Heart J. 1996;132:152–155
  48. Ruskin JN, Akhtar M, Damato AN, et al.  Abnormal Q waves in Wolff-Parkinson-White syndrome: incidence and clinical significance. JAMA. 1976;235:2727–2730
  49. Goldberger AL. Pseudo-infarct patterns in the Wolff-Parkinson-White syndrome: importance of Q wave-T wave vector discordance. J Electrocardiol. 1980;13:115–118
  50. Atié J, Brugada P, Brugada J, et al.  Clinical and electrophysiologic characteristics of patients with antidromic circus movement tachycardia in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1990;66:1082–1091
  51. De Chillou C, Rodriguez LM, Schlapfer J, et al.  Clinical characteristics and electrophysiologic properties of atrioventricular accessory pathways: importance of the accessory pathway location. J Am Coll Cardiol. 1992;20:666–671
  52. Archer S, Gornick C, Grund F, et al.  Exercise thallium testing in ventricular preexcitation. Am J Cardiol. 1987;59:1103–1106
  53. Gillette PC, Garson A, McNamara DG. Wolff-Parkinson-White syndrome in children: natural history and clinical spectrum [abstract]. Circulation. 1980;62:III-271
  54. Sung RJ, Gelband H, Castellanos A, et al.  Clinical and electrophysiologic observations in patients with concealed accessory atrioventricular bypass tracts. Am J Cardiol. 1977;40:839–847
  55. Coumel P, Attuel P. Reciprocating tachycardia in overt and latent pre-excitation: influence of functional bundle branch block on the rate of the tachycardia. Eur J Cardiol. 1974;1:423–436
  56. Wu D, Denes P, Amat-y-Leon F, et al.  Clinical, electrocardiographic, and electrophysiologic observations in patients with paroxysmal supraventricular tachycardia. Am J Cardiol. 1978;41:1045–1051
  57. Green M, Heddle B, Dassen W, et al.  Value of QRS alternans in determining the site of origin of narrow QRS supraventricular tachycardia. Circulation. 1983;68:368–373
  58. Morady F, DiCarlo JR, Baerman JM, et al.  Determinants of QRS alternans during narrow QRS tachycardia. J Am Coll Cardiol. 1987;9:489–499
  59. Teo WS, Klein GJ, Guiraudon GM, et al.  Multiple accessory pathways in the Wolff-Parkinson-White syndrome as a risk factor for ventricular fibrillation. Am J Cardiol. 1991;67:889–891
  60. Prystowsky EN, Fananapazir L, Packer DL, et al.  Wolff-Parkinson-White syndrome and sudden cardiac death. Cardiology. 1987;74:67–71
  61. Dreifus LS, Haiat R, Watanabe Y, et al.  Ventricular fibrillation: a possible mechanism of sudden death in patients with Wolff-Parkinson-White syndrome. Circulation. 1971;63:520–527
  62. Klein GJ, Prystowsky EN, Sharma AD, et al.  Asymptomatic Wolff-Parkinson-White: should we intervene?. Circulation. 1989;80:1902–1905
  63. Berkman NL, Lamb LE. The Wolff-Parkinson-White electrocardiogram: a follow-up study of 5 to 28 years. N Engl J Med. 1968;278:492–494
  64. Klein GJ, Bashore TM, Sellers TD, et al.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 1979;301:1080–1085
  65. Henthorn RW, Waldo AL, Anderson JL, et al. , the Flecainide Supraventricular Tachycardia Study Group   Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. Circulation. 1991;83:119–125
  66. Echt DS, Liebson PR, Brent M, et al. , the CAST Investigators   Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–788
  67. The Cardiac Arrhythmia Suppression Trial II Investigators . Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992;327:227–233
  68. Waldo AL, Camm AJ, deRuyter H, et al. , for the SWORD Investigators   Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996;348:7–12
  69. Jackman WM, Wang X, Friday KJ, et al.  Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991;324:1605–1611
  70. Leather RA, Leitch JW, Klein GJ, et al.  Radiofrequency catheter ablation of accessory pathways: a learning experience. Am J Cardiol. 1991;68:1651–1655
  71. Chen S, Chiang C, Tai C, et al.  Complications of diagnostic electrophysiologic studies and radiofrequency ablation in patients with tachyarrhythmias: an 8-year survey of 3,966 consecutive procedures in a tertiary referral center. Am J Cardiol. 1996;77:41–46
  72. Hogenhuis W, Stevens SK, Wang K, et al.  Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Circulation. 1993;88:437–446
  73. Boahene KA, Klein GJ, Yee R, et al.  Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol. 1990;16:1408–1414
  74. Sellers TD, Campbell RWF, Bashore TM, et al.  Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. Circulation. 1977;55:15–22
  75. Mcgovern B, Garan H, Ruskin JN. Precipitation of cardiac arrest by Verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med. 1986;104:791–794
  76. Prystowsky EN, Greer S, Packer DL, et al.  Beta-blocker therapy for the Wolff-Parkinson-White syndrome. Am J Cardiol. 1987;60:46D–50D
  77. Sellers TD, Bashore TM, Gallagher JJ. Digitalis in the pre-excitation syndrome: analysis during atrial fibrillation. Circulation. 1977;56:260–267
  78. Gulamhusein S, Ko P, Carruthers G, et al.  Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation. 1982;65:348–354
  79. Ludmer PL, McGowan NE, Antman EM, et al.  Efficacy of propafenone in Wolff-Parkinson-white syndrome: electrophysiologic findings and long-term follow-up. J Am Coll Cardiol. 1987;9:1357–1363
  80. Feld GK, Nademanee K, Stevenson W, et al.  Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. Am Heart J. 1988;115:102–107
  81. Madrid AH, Moro C, Marin Huerta E, et al.  Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol. PACE. 1992;15:2111–2115
  82. Kerr CR, Prystowsky EN, Smith WM, et al.  Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. Circulation. 1982;65:869–878
  83. Crozier I. Flecainide in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1992;70:26A–32A
  84. Rankin AC, Oldroyd KG, Chong E, et al.  Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J. 1989;62:195–203
  85. Dimarco JP, Sellers TD, Lerman BB, et al.  Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol. 1985;6:417–425
  86. Strickberger SA, Man S, Daoud EG, et al.  Adenosine-induced atrial arrhythmias: a prospective analysis. Ann Intern Med. 1997;127:417–422
  87. Hamer A, Peter T, Platt M, et al.  Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome. Am Heart J. 1981;101:600–612
  88. Tai DY, Chang M, Svinarich JT, et al.  Mechanisms of verapamil-induced conduction block in anomalous atrioventricular bypass tracts. J Am Coll Cardiol. 1985;5:311–317
  89. Rinkenberger RL, Prystowsky EN, Heger JJ, et al.  Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation. 1980;62:996–1010
  90. The Norwegian Multicenter Study Group . Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801–807
  91. B-Blockers Attack Trial Research Group . A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982;247:1707–1714
  92. Pritchett ELC, Wilkinson WE. Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias. Am J Cardiol. 1991;67:976–980
  93. Sasena S, Epstein AE, Lazzara R, et al.  Clinical investigation of antiarrhythmic devices: a statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Circulation. 1995;91:2097–2109
  94. Leitch JW, Klein GJ, Yee R, et al.  Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. Circulation. 1990;82:1718–1723
  95. Wellens HJJ, Rodriguez LM, Timmermans C, et al.  The asymptomatic patient with the Wolff-Parkinson-White electrocardiogram. PACE. 1997;20:2082–2086
  96. Zardini M, Yee R, Thakur RK, et al.  Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome: current perspectives. PACE. 1994;17:966–975
  97. Steinbeck G. Should radiofrequency current ablation be performed in asymptomatic patients with the Wolff-Parkinson-White syndrome. PACE. 1993;16:649–652
  98. Beckman KJ, Gallastegui JL, Bauman JL, et al.  The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1990;15:640–647
  99. Zipes DP, Garson A. Task Force 6: arrhythmias. J Am Coll Cardiol. 1994;24:892–899
  100. Paul T, Guccione P, Garson A. Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation. Am J Cardiol. 1990;65:318–321
  101. Drago F, Turchetta A, Calzolari P, et al.  Detection of atrial vulnerability by transesophageal atrial pacing and the relation of symptoms in children with Wolff-Parkinson-White syndrome and in a symptomatic control group. Am J Cardiol. 1994;74:400–401
  102. Garson A, Kanter RJ. Management of the child with Wolff-Parkinson-White syndrome and supraventricular tachycardia: model for cost effectiveness. J Cardiovasc Electrophysiol. 1997;8:1320–1326

☆ From the Divisions of Clinical Pharmacology and Cardiology, Department of Medicine, Duke University Medical Center.

☆☆ Dr Pritchett’s research in supraventricular arrhythmias was supported by grant M01-RR00030 from the National Center for Resources, National Institutes of Health, Bethesda, Md.

★ Guest Editor for this manuscript was Gervasio A. Lamas, MD, Mt Sinai Medical Center, Miami Beach, Fla.

★★ Reprint requests: Edward Pritchett, MD, Room 04280, Duke South Hospital, DUMC-3477, Durham, NC 27710.E-mail: ed.pritchett@duke.edu

♢ 0002-8703/99/$8.00 + 0   4/1/96975

PII: S0002-8703(99)70140-7

American Heart Journal
Volume 138, Issue 3 , Pages 403-413 , September 1999

Article Tools

* Image Usage & Resolution